DZ BANK/PUT/APOS PHAR/8/1/20.09.24 Stock

DE000DQ2GCU3

Market Closed - Boerse Frankfurt Warrants 15:35:16 2024-07-08 EDT
0.44 ^EUR	-6.38%

Current month	-24.14%
1 month	-27.87%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart APONTIS PHARMA AG

Chart DZ BANK/PUT/APOS PHAR/8/1/20.09.24

Latest news about APONTIS PHARMA AG

APONTIS PHARMA AG appoints CFO Thomas Zimmermann to the Management Board with a view to the strategic development of the Company	06-27	EQ
Apontis Pharma AG Appoints Thomas Zimmermann to the Management Board, Effective 1 July 2024	06-27	CI
APONTIS PHARMA continues to gear organization towards growth and internationalization – Renowned industry expert leads supply chain management	06-04	EQ
DD: APONTIS PHARMA AG: Thomas Milz, buy	05-14	EQ

More news

Quotes 5-day view

Date	Price	Change
24-07-08	0.44	-6.38%
24-07-05	0.47	-22.95%
24-07-04	0.61	-4.69%
24-07-03	0.64	0.00%
24-07-02	0.64	+14.29%

Real-time Boerse Frankfurt Warrants

Last update July 08, 2024 at 03:35 pm

More quotes

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	PUT
Underlying	APONTIS PHARMA AG
Issuer	DZ BANK
WKN	DQ2GCU
ISIN	DE000DQ2GCU3
Date issued	2024-04-09
Strike	8 €
Maturity	2024-09-20 (74 Days)
Parity	1 : 1
Emission price	1.02 €
Emission volume	N/A
Settlement	Barausgleich
Currency	EUR

Technical Indicators

Highest since issue	1.5 €
Lowest since issue	0.44 €
Spread	0.45 €
Spread %	51.72%

Company Profile

Apontis Pharma AG is a Germany-based manufacturer of pharmaceutical preparation. The company focuses on the commercialization of pharmaceutical products to General Practitioners and engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany.

Sector

More about the company